News
Public · Published
Ribbon Acquisition Received Notice of Noncompliance
On October 30, 2026, Ribbon Acquisition received a Nasdaq notice because its listed securities' market value stayed below $35 million for 30 consecutive business days, and it failed alternative equity or net income requirements. It has until April 28, 2027, to meet the market value threshold for 10 consecutive business days; its shares continue trading meanwhile.
Published:
Updated:
What happened
On October 30, 2026, Ribbon Acquisition received a Nasdaq notice because its listed securities’ market value stayed below $35 million for 30 consecutive business days, and it failed alternative equity or net income requirements. It has until April 28, 2027, to meet the market value threshold for 10 consecutive business days; its shares continue trading meanwhile.
Confirmed
Global impact / market context
The notice creates a deadline tied to the company’s ability to remain compliant with Nasdaq listing rules. If Ribbon Acquisition does not meet the stated threshold by April 28, 2027, its listing status could be at risk, potentially affecting where investors can trade its shares and how easily the company accesses public markets.
Analyst inference
The article reports a compliance shortfall, not a suspension: Ribbon Acquisition shares will continue trading on Nasdaq while the company has time to address it. The stated test is market value above $35 million for 10 consecutive business days; the article gives no recovery plan or financial detail.
Confirmed
What to watch
- Watch for whether Ribbon Acquisition’s market value reaches at least $35 million for 10 consecutive business days before the April 28, 2027 deadline. Confirmed
- The company could seek to meet the market value test or satisfy another listed requirement, but the article does not describe a specific plan. Analyst inference
- A failure to regain compliance by the deadline could put Nasdaq listing status at risk, potentially changing share-trading access for investors. Analyst inference
Evidence
- Original source link unavailable